The pharmaceutical company Johnson & Johnson is now known to many people because of its corona vaccine. A change at the top of the company is now being prepared.
The US pharmaceutical company Johnson & Johnson is preparing a change at the top of its board. Long-time chairman Alex Gorsky will vacate the post on January 3, 2022 and become executive chairman of the company’s board of directors, Johnson & Johnson announced.
His successor was Joaquin Duato, who like Gorsky has been working for the group for over three decades and has long been a member of the top management. Duato is currently the Vice Chairman of the Executive Committee of Johnson & Johnson. He should also move into the administrative board, which is superordinate to the executive board.
Gorsky, who has been at the helm since 2012, stated in the announcement that he wanted to give up the chairmanship for “family health reasons”. In addition, it is the right time for a change because of the company’s good shape. Investors reacted calmly, the share hardly moved after hours.
Jane Stock is a technology author, who has written for 24 Hours World. She writes about the latest in technology news and trends, and is always on the lookout for new and innovative ways to improve his audience’s experience.
